Polysaccharides, Bacterial

2 trials

Sponsors

Finlay Institute

Conditions

typhoid fever

Phase 2

Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age.

Active, not recruitingRPCEC00000056

Finlay Institutetyphoid fever

Start: 2002-01-09Updated: 2026-09-14

A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers.

Active, not recruitingRPCEC00000055

Finlay Institutetyphoid fever

Start: 2002-02-12Updated: 2026-09-14